K. Siriwattana

发表

Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand

A. Phrommintikul, D. Chinwong, J. Patumanond, 2015, Therapeutics and clinical risk management.

Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry

R. Krittayaphong, A. Phrommintikul, T. Chantrarat, 2019, Journal of geriatric cardiology : JGC.

Cardiovascular outcome in patients with high risk cardiovascular events in Nakornping Hospital

K. Siriwattana, K. Siriaree, K. Hinmali, 2021, Chiang Mai Medical Journal.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Adherence to Anticoagulant Guideline for Atrial Fibrillation Improves Outcomes in Asian Population

G. Lip, R. Krittayaphong, S. Apiyasawat, 2020, Stroke.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Mehrad Amin Eskandari, J. F. Tinto, A. Capucci, 2018, Indian heart journal.

Clinical indicators for recurrent cardiovascular events in acute coronary syndrome patients treated with statins under routine practice in Thailand: an observational study

A. Phrommintikul, D. Chinwong, J. Patumanond, 2015, BMC Cardiovascular Disorders.

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Michael A. Rodriguez, M. S. Lee, S. W. Park, 2019, Journal of the American Heart Association.

Effect of Beta-Blocker on Long-Term Major Cardiovascular Events in High Atherosclerotic Risk Population.

W. Wongcharoen, A. Phrommintikul, K. Udol, 2023, Cardiovascular drugs and therapy.

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

A. Phrommintikul, D. Chinwong, J. Patumanond, 2015, Therapeutics and clinical risk management.

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

Pedro F. Campos, Roger A. Nadeau, Jonathan B Sumner, 2021, BMJ.

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide

Roger A. Nadeau, Jonathan B Sumner, T. Furukawa, 2022, Clinical Research in Cardiology.

Low-density lipoprotein cholesterol of less than 70 mg/dL is associated with fewer cardiovascular events in acute coronary syndrome patients: a real-life cohort in Thailand

A. Phrommintikul, D. Chinwong, J. Patumanond, 2015, Therapeutics and clinical risk management.

statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency

A. Phrommintikul, D. Chinwong, J. Patumanond, 2015 .

Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry

Michael A. Rodriguez, Y. Y. Liu, J. F. Tinto, 2019, Journal of the American Heart Association.